Holger Willenbring

8.2k total citations · 1 hit paper
54 papers, 6.0k citations indexed

About

Holger Willenbring is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Holger Willenbring has authored 54 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Holger Willenbring's work include Liver physiology and pathology (21 papers), Pluripotent Stem Cells Research (13 papers) and Pancreatic function and diabetes (13 papers). Holger Willenbring is often cited by papers focused on Liver physiology and pathology (21 papers), Pluripotent Stem Cells Research (13 papers) and Pancreatic function and diabetes (13 papers). Holger Willenbring collaborates with scholars based in United States, Germany and Switzerland. Holger Willenbring's co-authors include Markus Grompe, Claudia Mitchell, Milton J. Finegold, Yassmine Akkari, Mark P. Foster, Susan B. Olson, Yann Malato, Yumi Torimaru, Muhsen Al-Dhalimy and Xin Wang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Holger Willenbring

54 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell fusion is the principal source of bone-marrow-derived hepatocytes

2003 1.2k citations Holger Willenbring, Milton J. Finegold et al. Nature profile →

Peers

Countries citing papers authored by Holger Willenbring

Since Specialization

Citations

This map shows the geographic impact of Holger Willenbring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Willenbring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Willenbring more than expected).

Fields of papers citing papers by Holger Willenbring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Willenbring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Willenbring. The network helps show where Holger Willenbring may publish in the future.

Co-authorship network of co-authors of Holger Willenbring

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Willenbring. A scholar is included among the top collaborators of Holger Willenbring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Willenbring. Holger Willenbring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system 2024 ·Nature Communications ·Lin Qi, (unknown), Aditi Sharma, (unknown), Erzhen Chen, (unknown), (unknown), Kevin E. Healy, Edward C. Hsiao, Holger Willenbring, Andreas Stahl	10
2	Human iPSC‐Derived Proinflammatory Macrophages cause Insulin Resistance in an Isogenic White Adipose Tissue Microphysiological System 2023 ·Small ·Lin Qi, (unknown), (unknown), (unknown), (unknown), Yuchen He, Peter‐James H. Zushin, Marko Gröger, Aditi Sharma, Holger Willenbring, Edward C. Hsiao, Andreas Stahl	9
3	Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages 2023 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Dounia Le Guillou, (unknown), Kayque A. Telles-Silva, Jacquelyn J. Maher, Edward C. Hsiao, Holger Willenbring	24
4	Induced Pluripotent Stem Cell–derived Hepatocytes From Patients With Nonalcoholic Fatty Liver Disease Display a Disease-specific Gene Expression Profile 2021 ·Gastroenterology ·Caroline C. Duwaerts, Dounia Le Guillou, (unknown), (unknown), Holger Willenbring, Aras N. Mattis, Jacquelyn J. Maher	15
5	De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation 2018 ·Nature ·Johanna Schaub, Kari A. Huppert, (unknown), (unknown), Ashley Cast, Bryan Donnelly, Rebekah Karns, Feng Chen, Milad Rezvani, Hubert Y. Luu, Aras N. Mattis, Anne‐Laure Rougemont, Philip Rosenthal, Stacey S. Huppert, Holger Willenbring	208
6	In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis 2016 ·Cell stem cell ·Milad Rezvani, Regina Español‐Suñer, Yann Malato, Laure Dumont, Andrew A. Grimm, Eike Kienle, (unknown), Ellen Wiedtke, (unknown), (unknown), Robert F. Schwabe, Carlos U. Corvera, Dirk Grimm, Holger Willenbring	105
7	A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration 2012 ·Journal of Clinical Investigation ·Raymond Ng, Guisheng Song, Garrett R. Roll, Niels Frandsen, Holger Willenbring	133
8	Core promoter recognition complex changes accompany liver development 2011 ·Proceedings of the National Academy of Sciences ·Joseph A. D’Alessio, Raymond Ng, Holger Willenbring, Robert Tjian	28
9	Stem Cells in Liver Diseases and Cancer 2011 ·Hepatology ·Carl Bart Rountree, Lopa Mishra, Holger Willenbring	77
10	Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration 2011 ·Journal of Clinical Investigation ·Yann Malato, (unknown), Nina Schürmann, Raymond Ng, Bruce Wang, Joan P. Zape, Mark A. Kay, Dirk Grimm, Holger Willenbring	323
11	Therapeutic Liver Reconstitution With Murine Cells Isolated Long After Death 2010 ·Gastroenterology ·Laura Erker, Hisaya Azuma, (unknown), Changsheng Guo, Susan L. Orloff, (unknown), Eric Benedetti, (unknown), Milton J. Finegold, Holger Willenbring, Markus Grompe	26
12	Induced pluripotent stem cell–derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice 2010 ·Journal of Clinical Investigation ·Silvia Espejel, Garrett R. Roll, K. John McLaughlin, Andrew Y. Lee, Jenny Y. Zhang, Diana J. Laird, Keisuke Okita, Shinya Yamanaka, Holger Willenbring	137
13	Micrornas Control Hepatocyte Proliferation During Liver Regeneration 2010 ·Hepatology ·Guisheng Song, Amar Deep Sharma, Garrett R. Roll, Raymond Ng, Andrew Y. Lee, Robert Blelloch, Niels Frandsen, Holger Willenbring	174
14	A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice 2008 ·Nature Protocols ·Claudia Mitchell, Holger Willenbring	420
15	On the Origin of the Term “Stem Cell” 2007 ·Cell stem cell ·Miguel Ramalho‐Santos, Holger Willenbring	158
16	Myeloid lineage progenitors give rise to vascular endothelium 2006 ·Proceedings of the National Academy of Sciences ·Alexis S. Bailey, Holger Willenbring, Shuguang Jiang, Daniel A. Anderson, (unknown), Melissa H. Wong, Markus Grompe, William H. Fleming	158
17	Bone marrow-derived cells fuse with normal and transformed intestinal stem cells 2006 ·Proceedings of the National Academy of Sciences ·Adnan Z. Rizvi, John Swain, Paige S. Davies, Alexis S. Bailey, (unknown), Holger Willenbring, Markus Grompe, William H. Fleming, Melissa H. Wong	203
18	Sustained Phosphorylation of Bid Is a Marker for Resistance to Fas-Induced Apoptosis During Chronic Liver Diseases 2006 ·Gastroenterology ·Arndt Vogel, Joseph E. Aslan, Holger Willenbring, Christian Klein, Milton J. Finegold, Howard T.J. Mount, Gary Thomas, Markus Grompe	27
19	Therapeutic cell fusion 2005 ·British journal of surgery ·Holger Willenbring	5
20	Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5α-reductase deficiency 1996 ·European Journal of Pediatrics ·Olaf Hiort, Holger Willenbring, Norbert Albers, Wolfgang Hecker, J. Engert, L. Dibbelt, Gernot H.G. Sinnecker	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact